LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,292 | -16.9% | 105 | 0.0% | 0.00% | – |
Q2 2023 | $7,571 | -27.5% | 105 | -26.1% | 0.00% | – |
Q1 2023 | $10,446 | +10.1% | 142 | 0.0% | 0.00% | – |
Q4 2022 | $9,486 | -21.0% | 142 | +3.6% | 0.00% | – |
Q3 2022 | $12,000 | +33.3% | 137 | +37.0% | 0.00% | – |
Q2 2022 | $9,000 | -30.8% | 100 | -13.8% | 0.00% | – |
Q1 2022 | $13,000 | -27.8% | 116 | +0.9% | 0.00% | -100.0% |
Q4 2021 | $18,000 | +12.5% | 115 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $16,000 | -23.8% | 115 | -28.6% | 0.00% | 0.0% |
Q2 2021 | $21,000 | 0.0% | 161 | +14.2% | 0.00% | 0.0% |
Q1 2021 | $21,000 | +40.0% | 141 | -4.1% | 0.00% | 0.0% |
Q4 2020 | $15,000 | -21.1% | 147 | -26.9% | 0.00% | 0.0% |
Q3 2020 | $19,000 | -9.5% | 201 | +5.2% | 0.00% | 0.0% |
Q2 2020 | $21,000 | +950.0% | 191 | +730.4% | 0.00% | – |
Q1 2020 | $2,000 | -99.0% | 23 | -96.9% | 0.00% | -100.0% |
Q3 2018 | $206,000 | – | 750 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |